Keyphrases
Atrial Fibrillation
100%
Ablation
38%
BMP10
34%
Persistent Atrial Fibrillation
32%
Atrial Arrhythmia
31%
Cardiovascular Disease
27%
Anticoagulation
27%
Older Adults
26%
Sodium Current
25%
Smartphone
25%
Arrhythmogenic Right Ventricular Cardiomyopathy
25%
Atrial Fibrillation Ablation
25%
Left Atrial
19%
Meta-analysis
19%
Flecainide
19%
Atrial Cardiomyocytes
18%
Biomolecules
18%
Fibroblast Growth Factor 23 (FGF23)
16%
Atrial Fibrillation Recurrence
15%
Optical Mapping
15%
Sodium Channel Blocker
15%
Adult Case
15%
Transient Ischemic Attack
14%
Stroke Ischemic
14%
Atrial High-rate Episodes
14%
Early Rhythm Control
14%
Catheter Ablation
14%
Medication Adherence
12%
Model Performance
12%
High-resolution
12%
Cardiac Electrophysiology
12%
Randomized Controlled Trial
12%
Patient Cohort
12%
PITX2
12%
Quality of Life
12%
Remote Design
12%
Functional Status
12%
Holter
12%
Systematic Meta-analysis
12%
Clinical Model
12%
Prognostic Model
12%
Atrial Conduction Abnormality
12%
Prolonged ECG Monitoring
12%
Risk of Bias
12%
Prior Stroke
12%
Risk Score
12%
Mobile Application
12%
Patient Association
12%
All-comers
12%
SCN5A
12%
Familial Atrial Fibrillation
12%
Fully Digital
12%
Biomarker Signature
12%
Shear Stress
12%
Edoxaban
12%
Anabolic Steroids
12%
Metabolism
12%
Cardiac Load
12%
Plakoglobin
12%
Angiopoietin-2
12%
Stress Load
12%
Anabolic Steroid Abuse
12%
Tertiary Level
12%
Inherited Cardiac Conditions
12%
ANGPT2
11%
Atrial Tachycardia
11%
Oral Anticoagulation
11%
Action Potential
10%
Hazard Ratio
9%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
9%
Potential Transient
8%
Calcium Transient
8%
Safety Outcomes
8%
Non-definite
8%
Cardiovascular Mortality
8%
Confidence Interval
7%
Efficacy Outcomes
6%
Heart Failure
6%
Clinical Differences
6%
Development Validation
6%
Internal Validation
6%
Development Impacts
6%
Model Impact
6%
Model Calibration
6%
Atrial Fibrillation Type
6%
Recurrence Prediction
6%
Risk of Bias Assessment
6%
Risk Evaluation
6%
Common Model
6%
Bibliographic Databases
6%
Impact Study
6%
Performance Estimate
6%
Biased Models
6%
Clinical Risk Prediction
6%
Calibration Metric
6%
Prediction Studies
6%
Parameter Type
6%
Forest Plot
6%
Risk Factors
6%
C-statistic
6%
Discrimination Index
6%
Impact Assessment
6%
Discriminatory Ability
6%
Validity Assessment
6%
Methodological Differences
6%
Robustness Evaluation
6%
Propafenone
6%
Arrhythmia
6%
Rhythm Control
6%
Wristband
5%
Clinical Outcomes
5%
P-wave
5%
Placebo Groups
5%
Major Bleeding
5%
Systemic Embolism
5%
Placebo
5%
Conduction Slowing
5%
Nav1.5
5%
Medicine and Dentistry
Atrial Fibrillation
69%
Anticoagulation
35%
Heart Atrium Arrhythmia
31%
Apoplexy
30%
Case Finding
25%
Sodium Current
25%
Arrhythmogenic Right Ventricular Dysplasia
25%
Flecainide
19%
Sodium Channel Blocker
17%
Cardiovascular Disease
16%
Rhythm
15%
Transient Ischemic Attack
15%
Cardiovascular Condition
14%
Electrocardiography Monitoring
14%
Functional Status
12%
Biological Marker
12%
Fibroblast Growth Factor 23
12%
Systematic Review
12%
Cardiac Electrophysiology
12%
Angiopoietin 2
12%
Meta-Analysis
12%
Quality of Life
12%
Edoxaban
12%
Medication Compliance
12%
Familial Atrial Fibrillation
12%
Heart Atrium Conduction
12%
Anabolic Agent
12%
Plakoglobin
12%
Electrocardiogram
12%
Randomized Controlled Trial
11%
Placebo
10%
Supraventricular Tachycardia
10%
Congestive Heart Failure
10%
Action Potential
10%
Cardiac Muscle Cell
10%
Atrium
10%
Cardiovascular System
9%
Isotopes of Calcium
8%
Point Mutation
8%
Excitability
8%
Photoelectric Plethysmography
7%
Nav1.5
7%
Propafenone
6%
Major Bleeding
5%
Action Potential Amplitude
5%
P Wave
5%
Cardiac Dysrhythmia
5%